Lytic replication of Epstein-Barr virus in human peripheral T-lymphocytes

1. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM (eds). Fields Virology. 5th ed. Philadelphia:Lippincott Williams and Wilkins; 2007. p. 2655-99.Search in Google Scholar

2. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-α gene by Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997; 100: 1969-79.10.1172/JCI119728Open DOISearch in Google Scholar

3. Mitarnun W, Suwiwat S, Pradutkanchana J, Saechan V, Ishida T, Takao S, Mori A. Epstein-Barr virusassociated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic and molecular analysis. Am J Hematol. 2002; 70:31-8.10.1002/ajh.10094Search in Google Scholar

4. Mitarnun W, Pradutkanchana J, Takao S, Saechan V, Suwiwat S, Ishida T. Epstein-Barr virus-associated non- Hodgkin’s lymphoma of B-cell origin, Hodgkin’s disease, acute lukaemia, and systemic lupus erythematosus: a serologic and molecular analysis. J Med Assoc Thai. 2002; 85:552-9.Search in Google Scholar

5. Mitarnun W, Pradutkanchana J, Ishida T. Epstein-Barr virus-associated nodal malignant lymphoma in Thailand. Asian Pac J Cancer Prev. 2004; 5:268-72.Search in Google Scholar

6. Mitarnun W, Saechan V, Suwiwat S, Pradutkanchana J, Takao S, Ishida T. Hepatic T-cell infiltrates in patients with peripheral T-cell proliferative disease/lymphomas: clinicopathologic and molecular analysis. Pathol Int. 2004b; 54:819-29.10.1111/j.1440-1827.2004.01766.xOpen DOISearch in Google Scholar

7. Suwiwat S, Pradutkanchana J, Ishida T, Mitarnun W Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T cell proliferative diseases. J Clin Virol. 2007; 40:277-83.10.1016/j.jcv.2007.08.013Open DOISearch in Google Scholar

8. Kieff E, Rickinson AB. Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, (eds). Fields Virology. 5th ed. Philadelphia: Lippincott Williams α Wilkins; 2007. p. 2603-54.Search in Google Scholar

9. Cohen JI. Virology and molecular biology of Epstein- Barr virus. In: Tselis A, Jenson HB (eds). Epstein-Barr virus. 1st ed. New York:Taylor & Francis; 2006. p. 21-37.10.3109/9781420014280.002Search in Google Scholar

10. O’Nions J, Allday MJ. Deregulation of the cell cycle by the Epstein- Barr virus. Adv Cancer Res. 2004; 92: 119-86. 10.1016/S0065-230X(04)92006-4Search in Google Scholar

11. Ninla-aesong P, Pradutkanchana J, Noipha K, Mitarnun W. Cytokine induction after Epstein-Barr virus infection of peripheral T-lymphocytes in vitro. Asian Biomed. 2010; 4:69-77.10.2478/abm-2010-0008Search in Google Scholar

12. Savard M, Belanger C, Tardif M, Gourde P, Flamand L, Gosselin J. Infection of primary human monocytes by Epstein-Barr virus. J Virol. 2000; 74:2612-9.10.1128/JVI.74.6.2612-2619.200011174910684275Open DOISearch in Google Scholar

13. Illges H, Braun M, Peter HH, Melchers I. Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes. Clin Exp Immunol. 2000; 122:270-6.10.1046/j.1365-2249.2000.01379.x190576611091285Search in Google Scholar

14. Moir S, Malaspina A, Ogwaro KM, Donoghue ET, Hallahan CW, Ehler LA, et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci USA. 2001; 98:10362-7.10.1073/pnas.1813478985696611504927Search in Google Scholar

15. Guan M, Romano G, Henderson EE. In situ RT-PCR detection of Epstein-Barr virus immediate-early transcripts in CD4+ and CD8+ T lymphocytes. Anticancer Res. 1998; 18:3171-80.Search in Google Scholar

16. Kelleher CA, Paterson RK, Dreyfus DH, Streib JE, Xu JW, Takase K, Jones JF, Gelfand EW. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: Simultaneous early expression of BZLF-1 and its repressor RAZ. Virology. 1995; 208: 685-95.10.1006/viro.1995.12007747440Search in Google Scholar

17. Paterson RL, Kelleher CA, Streib JE, Amankonah TD, Xu JW, Jones JF, Gelfand EW. Activation of human thymocytes after infection by EBV. J Immunol. 1995; 154:1440-9.10.4049/jimmunol.154.3.1440Search in Google Scholar

18. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearson DT. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA. 1984; 81:4510-4.10.1073/pnas.81.14.45103456206087328Open DOISearch in Google Scholar

19. Levy E, Ambrus J, Kahl L, Molina H, Tung K, Holers VM. T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE). Clin Exp Immunol. 1992; 90:235-44.10.1111/j.1365-2249.1992.tb07935.x15545941424280Search in Google Scholar

20. Fingeroth JD, Clabby ML, Strominger JD. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). J Virol. 1988; 62:1442-7.10.1128/jvi.62.4.1442-1447.19882531592831405Search in Google Scholar

21. Guan M, Zhang RD, Wu B, Henderson EE. Infection of primary CD4+ and CD8+ T lymphocytes by Epstein- Barr virus enhances human immunodeficiency virus expression. J Virol. 1996; 70:7341-6.10.1128/jvi.70.10.7341-7346.19961908018794395Search in Google Scholar

22. Braun M, Melchers I, Peter HH, Illges H. Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoproteins. Int Immunol. 1998 10:1197-202.10.1093/intimm/10.8.11979723706Search in Google Scholar